Key Statistics
About Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Analyst Ratings
View All →| Date | Firm | Rating |
|---|---|---|
| Jan 27, 2026 | TD COWEN | |
| Jan 23, 2026 | EQUISIGHTS | |
| Jan 21, 2026 | BERENBERG | |
| Jan 20, 2026 | ROTHSCHILD & CO REDBURN | |
| Jan 16, 2026 | GUGGENHEIM SECURITIES LLC |